Thermo Fisher Scientific
The world leader in serving science
|
|
| Public | |
| Traded as | : TMO S&P 500 Component |
| Industry | Laboratory equipment |
| Founded | 2006 by merger of Thermo Electron and Fisher Scientific |
| Headquarters | Waltham, Massachusetts, USA |
|
Key people
|
Marc N. Casper (President & CEO) Peter M. Wilver, (CFO) Joe Beery (CIO) |
| Products | Analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics |
| Revenue |
 $17 Billion USD (2015) |
|
$1.27 Billion USD (2013) |
|
|
Number of employees
|
57,000 (2017) |
| Website | www.thermofisher.com |
Thermo Fisher Scientific is an American multinational, biotechnology product development company, created in 2006 by the merger of Thermo Electron and Fisher Scientific. In April 2013, after a competitive bidding with Hoffmann-La Roche, Thermo Fisher acquired Life Technologies Corp for $13.6 billion in a deal that would rank the firm as one of the leading companies in the genetic testing and precision laboratory equipment markets.
Thermo Electron was co-founded in 1956 by George N. Hatsopoulos and Peter M Nomikos. Hatsopoulos is a MIT PhD in mechanical engineering and Nomikos a Harvard Business School graduate. It focused on providing analytical and laboratory products and services, and had revenues of over $2 billion in 2004.
Fisher Scientific was founded in 1902 by Chester G. Fisher from Pittsburgh. It focused on providing laboratory equipment, chemicals, supplies and services used in healthcare, scientific research, safety, and education.
On May 14, 2006, Thermo Electron and Fisher Scientific announced that they would merge in a tax-free, stock-for-stock exchange; the merged company was named Thermo Fisher Scientific. On November 9, 2006, the companies announced that the merger had been completed. However, the Federal Trade Commission ruled that this acquisition was anticompetitive with regard to centrifugal evaporators, requiring Fisher to divest Genevac. In April 2007, Genevac was sold to Riverlake Partners LLC and the merger closed with FTC approval.
...
Wikipedia